alexa Genetic Basis of DAF-12/Vitamin D Receptor (VDR) in Autoimmune Immunity, Autoimmune Diseases and Associated Cancers | OMICS International
ISSN: 2168-9849
Cloning & Transgenesis
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Genetic Basis of DAF-12/Vitamin D Receptor (VDR) in Autoimmune Immunity, Autoimmune Diseases and Associated Cancers

Yue Zhang*
Research Center, University of Montreal Hospital (CHUM), Notre-Dame Hospital, Montreal, Quebec H2L 4M1, Canada
Corresponding Author : Yue Zhang, PhD
CRCHUM, Notre-Dame Hospital
1560 Sherbrooke Street East
Pavillon DeSève, Room Y2625, Montreal
Quebec, Canada H2L 4M1
Tel: 1-514-890-8000 ext 23875
Fax: 1-514-412-7583
E-mail: [email protected]
Received September 13, 2013; Accepted September 16, 2013; Published September 18, 2013
Citation: Zhang Y (2013) Genetic Basis of DAF-12/Vitamin D Receptor (VDR) in Autoimmune Immunity, Autoimmune Diseases and Associated Cancers. Clon Transgen 2:e105. doi:10.4172/2168-9849.1000e105
Copyright: © 2013 Zhang Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Cloning & Transgenesis

Along with ageing, there is an increased risk for autoimmune diseases and/or cancers and no one is sure what causes such outcome. The vitamin D supplementation in the management of patients with rheumatic diseases and its controversary [1]. Indeed, the beneficial effects of vitamin D on Autoimmune Diseases (ADs) and cancers remain uncertain [1,2]. However, for the presence/absence of Vitamin D Receptor (VDR) within muscle [1], VDR might be transiently stable, similar to nuclear hormone receptor DAF-12, most closely-related to vertebrate VDR in nematode Caenorhabditis elegans [3-5]; thus some findings may be inconsistent even exacerbated with different genetic backgrounds. DAF-12 has its involvement in ageing and longevity [6-8]. Currently, the Rheumatoid Arthritis (RA) therapy is with a failure of anti-TNF therapy alone, but a better inhibition of human Th17-mediated synovial inflammation has been obtained alongside 1,25(OH)2D3−an active vitamin D metabolite [5]. Interestingly, human Matrix Metallopeptidase 3 (MMP3) gets involved in this processing and its homologue H36L18.1 as direct target candidate of DAF-12//VDR [3]. The highly-conserved targets (e.g. MMP3) of DAF-12/VDR [3] may be extrapolated to have synergic functions with its other evolutionarily- “fresh” targets (e.g. IL-6) [9,10]. Unless we truly understand such processes, some controversies may remain and precise therapies could hardly be developed to correct harmful cell behaviours in cancer or autoimmune diseases (ADs) [2,11]. Strikingly, one Genome-Wide Assocaition Study (GWAS) suggests that one allelic VDR variant may link to clinical autoimmune antibodies including anti-p150(TRIM33/ TIF-1γ)/p140(TRIM24/TIF-1α) [9], whose natural auto-antigens may be related to protein products encoded by TIF-1γ/α, their homologues flt-1 and nhl-2 as direct targets of DAF-12/VDR [3]. Our ChIP-chip screening for DAF-12/VDR target genes [3] actually revealed many overlaps with validated homologues identified in human VDR studies and significantly enriched near genes that are pathologically associated with ADs and cancer [12]. Further, genes near these DAF-12 binding sites include an extensive network of autophagy-related genes, interconnected microRNAs, longevity factors, genes homologous to cellular reprogramming and carcinogenesis in mammals [3,13], etc. (Figure 1, and Zhang Y, A&R, in preparation). Autophagic dysfunction may promote the development of ADs such as lupus [14]. Surprisingly, DAF-12/VDR binding is frequent in genomic regions of genes whose homologues in human encode products closely-related to autoantigens targeted by autoimmune antibodies [15]; which may cause diseases such as myositis, RA (Figure 1, and Zhang Y, A&R, comments in preparation). Genetically and/or physically, most of these targets intertwine in functional clusters/networks. Moreover, DAF-12/VDR acts as a capacitor to buffer internal/external challenges via multiple regulatory systems [3]. As a functional equivalent, human VDR may buffer detrimental effects of mutations of its targets, i.e. compensate to such mutations and ensure normal health. Environmental fluctuations, such as vitamin D deficiency and/ or a lack of UVB, likely enhance weaker phenotypes of mutations from VDR targets in patients, such synergic effects eventually lead to ADs and/or cancer. Data are waiting for completely clarifying these issues, but we predict, dys-expression of a subset of human VDR targets may cause cell-attractors shift, break down robustness of health, thus lead to ADs and carcinogenesis [13,16] (Figure 1). Other VDR targets function in response to danger signals, including hmgb1/hmg-1.2, grp78/hsp-3, hsp90/daf-2 [3]. Finally, VDR malfunction may result in over-expressions of reprogramming factors such as c-myc [17], lin-28 [3], and reprogram cells to cancerous stemlike [13,16] and/or immunogenic [18].
a. Multi-level control of the genes involved in development by DAF-12/VDR. The nuclear receptor directly regulates the expression of genes associated with autophagy, the Notch pathway, longevity, the heterochronic circuit, miRNA biogenesis and miRISC at the transcriptional level. Other regulators of miRNA activity, such as lin- 28 and stemness factors as mml-1/c-Myc are repressed by DAF-12. Together, miRNA and miRISC regulate the levels and translation of many heterochronic genes. Finally, DAF-12/VDR regulates its own expression and is also a target for miRNA. The system of different programs could intertwine well and merges as one perfect unit at beginning [3]. Here genetic regulatory network is partially built on physical association between DAF_12/VDR and its target genes; further detailed confirmation for some gene expressions is still needed. NCBI Aceview has been used for the identification of gene homologues online.
b. After developmental cell divisions complete and damage dilution reduces, a majority of transcriptional programs (gene expression profiles) continues, but the aging and tissue regeneration programs start. The ADs and cancer-initiation paradigm shift might emerge while the robustness of health breaks down. The system communications of different programs go awry during the procession. Finally, this process could be reprogrammable [3,13] and thanking Mr. David Salisbury (Vanderbilt University) for elements for the illustration.
References

Figures at a glance

Figure
Figure 1
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 3rd World Biotechnology Congress
    July 10-11, 2018 Bangkok, Thailand

Article Usage

  • Total views: 12051
  • [From(publication date):
    December-2013 - Nov 14, 2018]
  • Breakdown by view type
  • HTML page views : 8248
  • PDF downloads : 3803
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7